Raras
Buscar doenças, sintomas, genes...
Síndrome Pendred
ORPHA:705CID-10 · E07.1CID-11 · 5A00.02OMIM 274600DOENÇA RARA

A síndrome de Pendred (PDS) é uma doença genética clinicamente variável caracterizada por perda auditiva neurossensorial bilateral e bócio eutireóideo.

Mantido por Agente Raras·Colaborar como especialista →

Introdução

O que você precisa saber de cara

📋

A síndrome de Pendred (PDS) é uma doença genética clinicamente variável caracterizada por perda auditiva neurossensorial bilateral e bócio eutireóideo.

Publicações científicas
419 artigos
Último publicado: 2026

Escala de raridade

CLASSIFICAÇÃO ORPHANET · BRASIL 2024
1-9 / 100 000
Ultra-rara
<1/50k
Muito rara
1/20k
Rara
1/10k
Pouco freq.
1/5k
Incomum
1/2k
Prevalência
7.0
Europe
Início
Infancy
+ neonatal
🏥
SUS: Cobertura mínimaScore: 15%
CID-10: E07.1
🇧🇷Dados SUS / DATASUS
PROCEDIMENTOS SIGTAP (1)
0202080013
Teste do pezinho (triagem neonatal)newborn_screening
Você se identifica com essa condição?
O Raras está aqui pra te apoiar — com ou sem diagnóstico

Encontrou um erro ou informação desatualizada? Sugira uma correção →

Entender a doença

Do básico ao detalhe, leia no seu ritmo

Preparando trilha educativa...

Sinais e sintomas

O que aparece no corpo e com que frequência cada sintoma acontece

Partes do corpo afetadas

👂
Ouvidos
7 sintomas
📏
Crescimento
4 sintomas
🧠
Neurológico
2 sintomas
🫘
Rins
1 sintomas
🫁
Pulmão
1 sintomas

+ 6 sintomas em outras categorias

Características mais comuns

100%prev.
Deficiência auditiva neurossensorial congênita
Frequência: 15/15
93%prev.
Bócio
Frequência: 14/15
90%prev.
Hipoplasia da cóclea
Muito frequente (99-80%)
90%prev.
Aqueduto vestibular aumentado
Muito frequente (99-80%)
90%prev.
Anormalidade da orelha interna
Muito frequente (99-80%)
90%prev.
Deficiência auditiva neurossensorial
Muito frequente (99-80%)
21sintomas
Muito frequente (6)
Frequente (2)
Ocasional (9)
Sem dados (4)

Os sintomas variam de pessoa para pessoa. Abaixo estão as 21 características clínicas mais associadas, ordenadas por frequência.

Deficiência auditiva neurossensorial congênitaCongenital sensorineural hearing impairment
Frequência: 15/15100%
BócioGoiter
Frequência: 14/1593%
Hipoplasia da cócleaHypoplasia of the cochlea
Muito frequente (99-80%)90%
Aqueduto vestibular aumentadoEnlarged vestibular aqueduct
Muito frequente (99-80%)90%
Anormalidade da orelha internaAbnormality of the inner ear
Muito frequente (99-80%)90%

Linha do tempo da pesquisa

Publicações por ano — veja quando o interesse científico cresceu
Anos de pesquisa1desde 2026
Total histórico419PubMed
Últimos 10 anos148publicações
Pico202218 papers
Linha do tempo
2026Hoje · 2026📈 2022Ano de pico🧪 2023Primeiro ensaio clínico
Publicações por ano (últimos 10 anos)

Encontrou um erro ou informação desatualizada? Sugira uma correção →

Genética e causas

O que está alterado no DNA e como passa nas famílias

Genes associados

3 genes identificados com associação a esta condição. Padrão de herança: Autosomal recessive.

KCNJ10ATP-sensitive inward rectifier potassium channel 10Disease-causing germline mutation(s) inModerado
FUNÇÃO

May be responsible for potassium buffering action of glial cells in the brain (By similarity). Inward rectifier potassium channels are characterized by a greater tendency to allow potassium to flow into the cell rather than out of it (PubMed:8995301). Their voltage dependence is regulated by the concentration of extracellular potassium; as external potassium is raised, the voltage range of the channel opening shifts to more positive voltages (PubMed:8995301). The inward rectification is mainly d

LOCALIZAÇÃO

MembraneBasolateral cell membrane

VIAS BIOLÓGICAS (3)
Activation of G protein gated Potassium channelsInhibition of voltage gated Ca2+ channels via Gbeta/gamma subunitsPotassium transport channels
MECANISMO DE DOENÇA

Seizures, sensorineural deafness, ataxia, impaired intellectual development, and electrolyte imbalance

A complex disorder characterized by generalized seizures with onset in infancy, delayed psychomotor development, ataxia, sensorineural hearing loss, hypokalemia, metabolic alkalosis, and hypomagnesemia.

EXPRESSÃO TECIDUAL(Tecido-específico)
Brain Spinal cord cervical c-1
132.0 TPM
Brain Caudate basal ganglia
61.6 TPM
Substância negra
60.1 TPM
Brain Putamen basal ganglia
56.0 TPM
Córtex cerebral
49.6 TPM
OUTRAS DOENÇAS (4)
autosomal recessive nonsyndromic hearing loss 4EAST syndromePendred syndromeepisodic kinesigenic dyskinesia
HGNC:6256UniProt:P78508
SLC26A4PendrinDisease-causing germline mutation(s) inTolerante
FUNÇÃO

Sodium-independent transporter of chloride and iodide (PubMed:10192399, PubMed:11932316, PubMed:12107249, PubMed:16684826, PubMed:24051746). Mediates electroneutral chloride-bicarbonate, chloride-iodide and chloride-formate exchange with 1:1 stoichiometry (PubMed:10644529, PubMed:15155570, PubMed:24051746, PubMed:35601831). Mediates electroneutral iodide-bicarbonate exchange (By similarity)

LOCALIZAÇÃO

Cell membraneApical cell membrane

VIAS BIOLÓGICAS (1)
Inorganic anion exchange by SLC26 transporters
MECANISMO DE DOENÇA

Pendred syndrome

An autosomal recessive disorder characterized by congenital sensorineural hearing loss in association with thyroid goiter. The disorder may account for up to 10% of the cases of hereditary deafness. The deafness is most often associated with a Mondini cochlear defect. Deafness occurs early, starting at birth or during the first years of life. It is bilateral, sometimes asymmetrical, fluctuant and often progressive. Thyroid perturbations, such as thyroid goiter and/or hypothyroidism appear most commonly during adolescence, but they can be congenital or appear later.

EXPRESSÃO TECIDUAL(Tecido-específico)
Tireoide
136.5 TPM
Brain Frontal Cortex BA9
3.3 TPM
Brain Anterior cingulate cortex BA24
3.0 TPM
Córtex cerebral
2.7 TPM
Rim - Córtex
2.2 TPM
OUTRAS DOENÇAS (5)
Pendred syndromeautosomal recessive nonsyndromic hearing loss 4thyroid hypoplasiaathyreosis
HGNC:8818UniProt:O43511
FOXI1Forkhead box protein I1Disease-causing germline mutation(s) inTolerante
FUNÇÃO

Transcriptional activator required for the development of normal hearing, sense of balance and kidney function. Required for the expression of SLC26A4/PDS, JAG1 and COCH in a subset of epithelial cells and the development of the endolymphatic system in the inner ear. Also required for the expression of SLC4A1/AE1, SLC4A9/AE4, ATP6V1B1 and the differentiation of intercalated cells in the epithelium of distal renal tubules (By similarity)

LOCALIZAÇÃO

Nucleus

EXPRESSÃO TECIDUAL(Tecido-específico)
Rim - Córtex
32.3 TPM
Rim - Medula
24.0 TPM
Glândula salivar
8.9 TPM
Skin Sun Exposed Lower leg
4.0 TPM
Skin Not Sun Exposed Suprapubic
2.5 TPM
INTERAÇÕES PROTEICAS (4)
OUTRAS DOENÇAS (3)
autosomal recessive nonsyndromic hearing loss 4autosomal recessive distal renal tubular acidosisPendred syndrome
HGNC:3815UniProt:Q12951

Variantes genéticas (ClinVar)

965 variantes patogênicas registradas no ClinVar.

🧬 FOXI1: NM_012188.5(FOXI1):c.505A>G (p.Asn169Asp) ()
🧬 FOXI1: NM_012188.5(FOXI1):c.638G>T (p.Arg213Leu) ()
🧬 FOXI1: NM_012188.5(FOXI1):c.376T>A (p.Tyr126Asn) ()
🧬 FOXI1: NM_012188.5(FOXI1):c.879C>A (p.Ser293Arg) ()
🧬 FOXI1: NM_012188.5(FOXI1):c.748dup (p.Asp250fs) ()
Ver todas no ClinVar

Classificação de variantes (ClinVar)

Distribuição de 662 variantes classificadas pelo ClinVar.

132
530
Patogênica (19.9%)
VUS (80.1%)
VARIANTES MAIS SIGNIFICATIVAS
SLC26A4: NC_000007.13:g.(?_107301272)_(107303881_107312582)del [Pathogenic]
SLC26A4: NM_000441.2(SLC26A4):c.1517T>G (p.Leu506Arg) [Likely pathogenic]
SLC26A4: NM_000441.2(SLC26A4):c.1028_1029insTCAG (p.Ser344fs) [Pathogenic]
SLC26A4: NM_000441.2(SLC26A4):c.1149+2T>C [Pathogenic]
SLC26A4: NM_000441.2(SLC26A4):c.1149G>C (p.Gln383His) [Uncertain significance]

Diagnóstico

Os sinais que médicos procuram e os exames que confirmam

Carregando...

Tratamento e manejo

Remédios, cuidados de apoio e o que precisa acompanhar

Pipeline de tratamentos
Pipeline regulatório — de medicamentos já aprovados a drogas em pesquisa exploratória.
·Pré-clínico1
Medicamentos catalogadosEnsaios clínicos· 0 medicamentos · 1 ensaio
Carregando informações de tratamento...

Onde tratar no SUS

Hospitais de referência no Brasil e o protocolo oficial do SUS (PCDT)

🇧🇷 Atendimento SUS — Síndrome Pendred

🗺️

Selecione um estado ou use sua localização para ver resultados.

Dados de DATASUS/CNES, SBGM, ABNeuro e Ministério da Saúde. Sempre confirme a disponibilidade diretamente com o estabelecimento.

Pesquisa ativa

Ensaios clínicos abertos e novidades científicas recentes

Pesquisa e ensaios clínicos

1 ensaios clínicos encontrados.

Distribuição por fase
Ver todos no ClinicalTrials.gov
🧪 Está conduzindo uma pesquisa?
Divulgue para pacientes e familiares que acompanham esta doença.
Divulgar pesquisa →

Publicações mais relevantes

📖Melhor nível de evidência: Revisão
Timeline de publicações
144 papers (10 anos)
#1

Foxi1 regulates multipotent mucociliary progenitors and ionocyte specification through transcriptional and epigenetic mechanisms.

PLoS biology2026 Jan

Foxi1 is a master regulator of ionocytes (ISCs/INCs) across species and organs. Two subtypes of ISCs exist, and both α- and β-ISCs regulate pH- and ion-homeostasis in epithelia. Gain and loss of FOXI1 function are associated with human diseases, including Pendred syndrome, male infertility, renal acidosis, and cancers. Foxi1 was predominantly studied in the context of ISC specification, however, reports indicate additional functions in early and ectodermal development. Here, we re-investigated the functions of Foxi1 in Xenopus laevis embryonic mucociliary epidermis developpment and found a novel function for Foxi1 in the generation of Notch-ligand expressing mucociliary multipotent progenitors (MPPs). We demonstrate that MPPs are a distinct sub-population of epidermal cells in which Foxi1 has two concentration-dependent functions: At low levels, Foxi1 maintains ectodermal competence in MPPs through transcriptional and epigenetic mechanisms, while at high levels, Foxi1 induces a multi-step process of ISC specification and differentiation in cooperation with Ubp1 and Dmrt2. We further describe how foxi1 expression is affected through auto- and Notch-regulation, and how this developmental program affects mucociliary patterning. Together, we reveal novel functions for MPPs and Foxi1 in Xenopus mucociliary epidermis formation, relevant to our understanding of vertebrate development and human disease.

#2

Thyroid and breast carcinomas in a patient with Pendred syndrome: a case report and literature review.

Frontiers in oncology2026

Goiter in the course of Pendred syndrome may in rare cases be associated with thyroid cancer (about 1% of all Pendred syndrome patients). The coexistence of Pendred syndrome with both thyroid and breast cancer is an even rarer condition reported in only one case. We report a case of a patient diagnosed with Pendred syndrome, who concurrently developed follicular thyroid cancer and breast cancer. After receiving four cycles of neoadjuvant THP (trastuzumab + pertuzumab + docetaxel) chemotherapy, the patient underwent left mastectomy and bilateral thyroidectomy. Postoperative pathology confirmed follicular thyroid carcinoma, while no residual malignancy was detected in the breast tissue. Genetic analysis of the SLC26A4 gene revealed mutations in intron 7 (c.919.2A>G) and exon 3 (c.170C>A) on chromosome 7. To minimize the risk of axillary metastasis, the patient received postoperative breast radiotherapy. At over one year of follow-up, there were no signs of recurrence for either cancer. The coexistence of Pendred syndrome with both thyroid and breast carcinoma is extremely rare, and the underlying mechanisms remain uncertain. Current evidence does not support SLC26A4 as a driver oncogene, and the concurrence of malignancies may represent a coincidental finding rather than a causal association. Nonetheless, comprehensive genetic testing should be considered for patients with Pendred syndrome, and family-based screening is recommended once pathogenic SLC26A4 variants are identified. Long-term surveillance of the thyroid and breast is essential for early detection and timely management of potential malignancies in these patients.

#3

Assessing the Functional Significance of Novel and Rare Variants of the SLC26A4 Gene Found in Patients with Hearing Loss by Minigene Assay.

International journal of molecular sciences2025 Nov 04

The SLC26A4 gene is one of the key genes involved in the etiology of hearing loss. It encodes pendrin, a transmembrane transporter protein functioning as a multifunctional anion exchanger. About 600 pathogenic SLC26A4 variants are known to cause either nonsyndromic recessive hearing loss (DFNB4) or Pendred syndrome (hearing loss and thyroid dysfunction). While most pathogenic variants occur in coding regions and disrupt pendrin structure or function, about 25% are thought to impair splicing. For many, pathogenicity has been assessed only in silico, with limited experimental confirmation. We identified several novel and rare SLC26A4 variants in patients with hearing loss from the Tyva and Altai Republics (Southern Siberia, Russia). Based on splicing predictions, six variants-intronic c.2034+1G>A, c.1545-168A>G, c.1708-125T>C, c.1708-18T>A, c.1804-31C>T, and exonic c.942A>G-were selected for analysis using a minigene assay. The results of in vitro analysis only partially matched in silico predictions: c.2034+1G>A caused aberrant splicing; c.1708-18T>A led to exon 16 skipping only in a small proportion of transcripts; the remaining variants showed no detectable splicing effect. These findings underscore the need for integrating in silico predictions with in vitro validation to accurately assess the functional impact of genetic variants, enabling their correct interpretation and reliable molecular diagnosis.

#4

Low Efficiency of Homology-Independent Targeted Integration for CRISPR/Cas9 Correction in the Vicinity of the SLC26A4 c.919-2A>G Variant.

International journal of molecular sciences2025 May 22

Recessive variants of SLC26A4 are a common cause of hereditary hearing impairment and are responsible for non-syndromic enlarged vestibular aqueducts and Pendred syndrome. Patients with bi-allelic SLC26A4 variants often suffer from fluctuating hearing loss and recurrent vertigo, ultimately leading to severe to profound hearing impairment. However, there are currently no satisfactory prevention or treatment options for this condition. The CRISPR/Cas9 genome-editing technique is a well-known tool for correcting point mutations or manipulating genes and shows potential therapeutic applications for hereditary disorders. In this study, we used the homology-independent targeted integration (HITI) strategy to correct the SLC26A4 c.919-2A>G variant, the most common SLC26A4 variant in the Han Chinese population. Next-generation sequencing was performed to evaluate the editing efficiency of the HITI strategy. The results showed that only 0.15% of the reads successfully exhibited HITI integration, indicating that the c.919-2 region may not be a suitable region for HITI selection. This suggests that other site selection or insertion strategies may be needed to improve the efficiency of correcting the SLC26A4 c.919-2A>G variant. This experience may serve as a valuable reference for other researchers considering CRISPR target design in this region. Pendred syndrome was first described in 1896 and is defined by a combination of sensorineural hearing loss and thyroid goiter, with or without hypothyroidism. This condition is most commonly caused by an autosomal recessive mutation in the SLC26A4 gene, leading to a defect in the pendrin protein. Pendred syndrome accounts for 7% to 15% of all cases of congenital deafness, typically presenting as bilateral deafness. Most patients (66%) will also experience balance problems due to an enlarged vestibular aqueduct. Hearing loss may not be complete at birth and can progress stepwise during early childhood. Head trauma may accelerate hearing deterioration in individuals with Pendred syndrome. Similarly, goiter may not be clinically evident at birth and typically develops over late childhood to early adulthood, even if the patient remains euthyroid. Regular thyroid monitoring is therefore essential, even in asymptomatic individuals. Treatment for Pendred syndrome is primarily symptomatic and supportive, and may include the use of hearing aids, balance rehabilitation, and thyroid hormone supplementation. Genetic counseling is also recommended to determine the carrier status and assess the risk to other family members.

#5

Comparative genomic profiling of SLC26A4-expressing cells in the inner ear and other organs.

PloS one2025

Pendred syndrome and autosomal recessive non-syndromic hearing loss, type 4 (DFNB4), are associated with mutations in SLC26A4 that encodes the anion transporter SLC26A4 (pendrin). SLC26A4 is expressed in mitochondria-rich cells of the endolymphatic sac, spindle and root cells in the cochlear lateral wall, transitional cells in the vestibular organs, follicular cells in the thyroid, and type B intercalated cells in the kidney. This study aimed to assess the gene profiles of murine Slc26a4-expressing cells to better understand the regulatory mechanisms and functions of SLC26A4. Publicly available murine single-cell or single-nucleus RNA-sequencing (RNA-seq) datasets from the endolymphatic sac, cochlear lateral wall, utricle, kidney, airway, epididymis, and salivary glands were collected. After quality control, principal component analysis and clustering, distinct cell populations were identified, and differentially expressed genes (DEGs) were analyzed. The datasets were integrated for comparison across multiple tissues and organs. The results revealed no shared genetic profile among inner ear Slc26a4-expressing cells, with Slc26a4 being the only shared DEG, suggesting that regulatory genes may include low expression transcripts, splicing variants, or long non-coding RNAs undetectable by single-cell analysis. Comparative analysis within the ionocyte family identified distinct DEGs such as Insrr and Hmx2 in Slc26a4-expressing cells from the endolymphatic sac and kidneys, potentially significant in ion homeostasis and SLC26A4 regulation. This study highlights the specificity and complexity of SLC26A4 expression and highlights the challenges and limitations of single-cell analysis. Future research should address regulatory elements such as low-expression genes, splicing variants, and non-coding RNAs to enhance our understanding of SLC26A4 regulation across various cellular contexts.

Publicações recentes

Ver todas no PubMed

📚 EuropePMC192 artigos no totalmostrando 146

2026

Thyroid and breast carcinomas in a patient with Pendred syndrome: a case report and literature review.

Frontiers in oncology
2026

Foxi1 regulates multipotent mucociliary progenitors and ionocyte specification through transcriptional and epigenetic mechanisms.

PLoS biology
2025

Concomitant Mutations in the Thyroglobulin and SLC26A4 Genes Leading to Fetal Goiter and Congenital Hypothyroidism in a Patient With Pendred Syndrome.

Case reports in endocrinology
2025

Assessing the Functional Significance of Novel and Rare Variants of the SLC26A4 Gene Found in Patients with Hearing Loss by Minigene Assay.

International journal of molecular sciences
2025

[Congenital hearing loss in children].

Ugeskrift for laeger
2025

Diagnostic yield of whole exome sequencing with targeted gene analysis in prelingual sensorineural hearing loss in Thailand.

Scientific reports
2025

Prevalence of pendrin defects in sudanese families with congenital hypothyroidism.

Endocrine
2025

Novel SLC26A4 variant in Pendred syndrome with non-classical inheritance: a case report.

European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery
2025

Low Efficiency of Homology-Independent Targeted Integration for CRISPR/Cas9 Correction in the Vicinity of the SLC26A4 c.919-2A>G Variant.

International journal of molecular sciences
2025

Genetic heterogeneity in patients with enlarged vestibular aqueduct and Pendred syndrome.

Molecular medicine (Cambridge, Mass.)
2025

Influence of melanin and macrophage activation on hearing loss in SLC26A4 deficient mice.

Neurobiology of disease
2025

Comparative analysis of haplotypes carrying pathogenic variants c.1545T>G, c.2027T>A and c.919-2A>G of the SLC26A4 gene in patients with hearing loss from the Tyva Republic (Southern Siberia).

Vavilovskii zhurnal genetiki i selektsii
2025

Novel genetic determinants contribute to hearing loss in a central European cohort with enlarged vestibular aqueduct.

Molecular medicine (Cambridge, Mass.)
2025

Inhibitors of the ubiquitin‑proteasome system rescue cellular levels and ion transport function of pathogenic pendrin (SLC26A4) protein variants.

International journal of molecular medicine
2025

Advances in Understanding the Molecular Dynamics of Autosomal Dominant Auditory Neuropathy: Unveiling a Novel DIAPH3 Gene Variant Associated With Sensorineural Hearing Loss and Bilateral Vestibular Aqueduct Enlargement.

Journal of audiology &amp; otology
2025

Comparative genomic profiling of SLC26A4-expressing cells in the inner ear and other organs.

PloS one
2025

Clinical Phenotypic Characterization of the SLC26A4 Mutation in Pendred Syndrome/Nonsyndromic Enlarged Vestibular Aqueduct.

The Laryngoscope
2024

Hearing loss with two pathogenic SLC26A4 variants and positive thyroid autoantibody: A case report.

Clinical pediatric endocrinology : case reports and clinical investigations : official journal of the Japanese Society for Pediatric Endocrinology
2024

CRISPR/Cas9-mediated exon skipping to restore premature translation termination in a DFNB4 mouse model.

Gene therapy
2024

Solute Carrier Family 26 Member 4 (SLC26A4), A Potential Therapeutic Target for Asthma.

Journal of respiratory biology and translational medicine
2024

Variability in Inner Ear Morphology Among a Family With Pendred Syndrome Due to a SLC26A4 Gene Variant.

The Annals of otology, rhinology, and laryngology
2024

Incomplete partition type II in its various manifestations: isolated, in association with EVA, syndromic, and beyond; a multicentre international study.

Neuroradiology
2024

Functional Studies of Deafness-Associated Pendrin and Prestin Variants.

International journal of molecular sciences
2024

Clinically Relevant Germline Variants in Children With Nonmedullary Thyroid Cancer.

The Journal of clinical endocrinology and metabolism
2024

Enlarged vestibular aqueduct as a cause of postneonatal deafness.

Acta otorrinolaringologica espanola
2024

Mechanism of anion exchange and small-molecule inhibition of pendrin.

Nature communications
2024

Carrier frequency estimation of pathogenic variants of autosomal recessive and X-linked recessive mendelian disorders using exome sequencing data in 1,642 Thais.

BMC medical genomics
2024

Pendrin: linking acid base to blood pressure.

Pflugers Archiv : European journal of physiology
2023

Syndromic Hearing Loss in Children.

Neuroimaging clinics of North America
2023

Novel small molecule-mediated restoration of the surface expression and anion exchange activity of mutated pendrin causing Pendred syndrome and DFNB4.

Biomedicine &amp; pharmacotherapy = Biomedecine &amp; pharmacotherapie
2023

Causes of hearing loss and implantation age in a cohort of Danish pediatric cochlear implant recipients.

International journal of pediatric otorhinolaryngology
2023

Analysis of clinical characteristics of thyroid phenotype in Pendred syndrome based on multiple databases.

European review for medical and pharmacological sciences
2023

Single-cell RNA-sequencing of stria vascularis cells in the adult Slc26a4-/- mouse.

BMC medical genomics
2023

Quantitative analysis and correlative evaluation of video-oculography, micro-computed tomography, and histopathology in Pendrin-null mice.

Neurobiology of disease
2023

Asymmetric pendrin homodimer reveals its molecular mechanism as anion exchanger.

Nature communications
2023

Insight into the Natural History of Pathogenic Variant c.919-2A>G in the SLC26A4 Gene Involved in Hearing Loss: The Evidence for Its Common Origin in Southern Siberia (Russia).

Genes
2023

Evidence of vestibular dysfunction in children with enlarged vestibular aqueduct.

International journal of pediatric otorhinolaryngology
2022

Case report: A case of SLC26A4 mutations causing pendred syndrome and non-cystic fibrosis bronchiectasis.

Frontiers in pediatrics
2023

A Prospective Study of Genetic Variants in Infants with Congenital Unilateral Sensorineural Hearing Loss.

Journal of clinical medicine
2022

SLC26A4 Phenotypic Variability Influences Intra- and Inter-Familial Diagnosis and Management.

Genes
2022

Analysis of SLC26A4, FOXI1, and KCNJ10 Gene Variants in Patients with Incomplete Partition of the Cochlea and Enlarged Vestibular Aqueduct (EVA) Anomalies.

International journal of molecular sciences
2023

Pendred's syndrome diagnosed in adulthood at the high resolution thyroid clinic.

Endocrinologia, diabetes y nutricion
2023

Cochlear Implantation in Children with Enlarged Vestibular Aqueduct: A Systematic Review of Surgical Implications and Outcomes.

Ear and hearing
2022

Histopathological Features of Pendred Syndrome Thyroids Align with Differences in the Expression of Thyroid-Specific Markers, Apical Iodide Transporters, and Ciliogenesis Process.

Endocrine pathology
2022

Molecular Features of SLC26A4 Common Variant p.L117F.

Journal of clinical medicine
2023

Congenital hypothyroidism as the initial presentation of pendred syndrome associated with mutated IVS7-2A>G in SLC26A4 gene in a Taiwanese neonate.

Pediatrics and neonatology
2022

SLC26A4 mutation in Pendred syndrome with hypokalemia: A case report.

Medicine
2022

Molecular diagnose of a large hearing loss population from China by targeted genome sequencing.

Journal of human genetics
2022

Extended genetic diagnostics for children with profound sensorineural hearing loss by implementing massive parallel sequencing. Diagnostic outcome, family experience and clinical implementation.

International journal of pediatric otorhinolaryngology
2022

TMED3 Complex Mediates ER Stress-Associated Secretion of CFTR, Pendrin, and SARS-CoV-2 Spike.

Advanced science (Weinheim, Baden-Wurttemberg, Germany)
2022

Blended Phenotype of Pelger-Huet Anomaly with Osteochondroma and Autosomal Recessive Deafness with Enlarged Vestibular Aqueduct.

Molecular syndromology
2022

Case of delayed presentation of Pendred syndrome with a large goitre causing a life-threatening airway obstruction.

BMJ case reports
2022

Rescue of mis-splicing of a common SLC26A4 mutant associated with sensorineural hearing loss by antisense oligonucleotides.

Molecular therapy. Nucleic acids
2022

Enlarged Vestibular Aqueduct: Disease Characterization and Exploration of Potential Prognostic Factors for Cochlear Implantation.

Otology &amp; neurotology : official publication of the American Otological Society, American Neurotology Society [and] European Academy of Otology and Neurotology
2022

Rapid Genetic Diagnosis for Okinawan Patients with Enlarged Vestibular Aqueduct Using Single-Stranded Tag Hybridization Chromatographic Printed-Array Strip.

Journal of clinical medicine
2022

Custom Next-Generation Sequencing Identifies Novel Mutations Expanding the Molecular and clinical spectrum of isolated Hearing Impairment or along with defects of the retina, the thyroid, and the kidneys.

Molecular genetics &amp; genomic medicine
2021

Different Rates of the SLC26A4-Related Hearing Loss in Two Indigenous Peoples of Southern Siberia (Russia).

Diagnostics (Basel, Switzerland)
2022

Clinical and genetic analysis of children with hearing loss and bilateral enlarged vestibular aqueducts.

International journal of pediatric otorhinolaryngology
2021

Pendred Syndrome, or Not Pendred Syndrome? That Is the Question.

Genes
2021

Genetic Determinants of Non-Syndromic Enlarged Vestibular Aqueduct: A Review.

Audiology research
2021

Reclassification of Whole Exome Sequencing-derived Genetic Variants in Pendred Syndrome with ACMG/AMP Standards.

Global medical genetics
2022

Genetic architecture and phenotypic landscape of SLC26A4-related hearing loss.

Human genetics
2021

Pendred Syndrome with C Cell Hyperplasia.

Endocrine pathology
2022

Molecular genetic landscape of hereditary hearing loss in Pakistan.

Human genetics
2021

Speech Perception and Production in Cochlear Implant Recipients with Pendred Syndrome.

Balkan medical journal
2021

Vestibular Function in Pendred Syndrome: Intact High Frequency VOR and Saccular Hypersensitivity.

Otology &amp; neurotology : official publication of the American Otological Society, American Neurotology Society [and] European Academy of Otology and Neurotology
2021

Follicular thyroid cancer in a patient with Pendred syndrome.

Annales d'endocrinologie
2021

Cochlear implantation in patients with Pendred syndrome.

American journal of otolaryngology
2021

Transcriptomic Analysis Reveals an Altered Hcy Metabolism in the Stria Vascularis of the Pendred Syndrome Mouse Model.

Neural plasticity
2021

Toward the Pathogenicity of the SLC26A4 p.C565Y Variant Using a Genetically Driven Mouse Model.

International journal of molecular sciences
2021

Molecular diagnosis of SLC26A4-related hereditary hearing loss in a group of patients from two provinces of Iran.

Intractable &amp; rare diseases research
2021

Interpreting pendred syndrome as a foetal hydrops: Clinical and animal model evidence.

Journal of vestibular research : equilibrium &amp; orientation
2021

Clinical heterogeneity of the SLC26A4 gene in UAE patients with hearing loss and bioinformatics investigation of DFNB4/Pendred syndrome missense mutations.

International journal of pediatric otorhinolaryngology
2020

Outcomes of Cochlear Implantation in Patients with Pendred syndrome: A Systematic Review and Narrative Synthesis.

The journal of international advanced otology
2020

Pendred syndrome with hyperthyroidism.

Journal of rural medicine : JRM
2021

Enlarged vestibular aqueduct and Mondini Malformation: audiological, clinical, radiologic and genetic features.

European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery
2020

Genotype-Phenotype Correlation for Predicting Cochlear Implant Outcome: Current Challenges and Opportunities.

Frontiers in genetics
2020

An iPSC line (TYWHSTi002-A) derived from a patient with Pendred syndrome caused by compound heterozygous mutations in the SLC26A4 gene.

Stem cell research
2020

Maternal UPD of chromosome 7 in a patient with Silver-Russell syndrome and Pendred syndrome.

Journal of clinical laboratory analysis
2020

Viewing Cortical Collecting Duct Function Through Phenotype-guided Single-Tubule Proteomics.

Function (Oxford, England)
2020

A phase I/IIa double blind single institute trial of low dose sirolimus for Pendred syndrome/DFNB4.

Medicine
2020

[Enlarged vestibular aqueduct syndrome-dehiscence syndromes-honeycomb mastoid : Pathophysiology and evidence for clinical differentiation].

HNO
2020

Congenital chloride diarrhea and Pendred syndrome: case report of siblings with two rare recessive disorders of SLC26 family genes.

BMC medical genetics
2020

Bimodal strategy for excellent audiological rehabilitation in a subject with a novel nonsense mutation of the SLC26A4 gene: A case report.

International journal of pediatric otorhinolaryngology
2020

Genetic Hearing Loss Associated With Autoinflammation.

Frontiers in neurology
2020

Digenic inheritance of mutations in EPHA2 and SLC26A4 in Pendred syndrome.

Nature communications
2021

Inner Ear Malformations in Congenital Deafness Are Not Associated with Increased Risk of Breech Presentation.

Fetal and pediatric pathology
2020

Inhibiting SLC26A4 reverses cardiac hypertrophy in H9C2 cells and in rats.

PeerJ
2020

Computational analysis of functional single nucleotide polymorphisms associated with SLC26A4 gene.

PloS one
2020

DNAJC14 Ameliorates Inner Ear Degeneration in the DFNB4 Mouse Model.

Molecular therapy. Methods &amp; clinical development
2020

Receptive language acquisition in a pediatric population with Pendred syndrome and non-syndromic enlarged vestibular aqueduct.

Acta oto-laryngologica
2019

Gene therapy for hereditary hearing loss by SLC26A4 mutations in mice reveals distinct functional roles of pendrin in normal hearing.

Theranostics
2019

Association of SLC26A4 mutations, morphology, and hearing in pendred syndrome and NSEVA.

The Laryngoscope
2020

Systematic quantification of the anion transport function of pendrin (SLC26A4) and its disease-associated variants.

Human mutation
2019

Comprehensive analysis of syndromic hearing loss patients in Japan.

Scientific reports
2019

Generation of a human iPS cell line (CGMH.SLC26A4919-2) from a Pendred syndrome patient carrying SLC26A4 c.919-2A>G splice-site mutation.

Stem cell research
2019

Congenital goitrous hypothyroidism is caused by dysfunction of the iodide transporter SLC26A7.

Communications biology
2019

SLC26A4-linked CEVA haplotype correlates with phenotype in patients with enlargement of the vestibular aqueduct.

BMC medical genetics
2019

A pathogenic variant in SLC26A4 is associated with Pendred syndrome in a consanguineous Iranian family.

International journal of audiology
2019

A knock-in mouse model of Pendred syndrome with Slc26a4 L236P mutation.

Biochemical and biophysical research communications
2019

Hoffmann's Syndrome Secondary to Pendred Syndrome: A Rare Case.

Cureus
2019

Mimicry and well known genetic friends: molecular diagnosis in an Iranian cohort of suspected Bartter syndrome and proposition of an algorithm for clinical differential diagnosis.

Orphanet journal of rare diseases
2019

The Natural History of Hearing Loss in Pendred Syndrome and Non-Syndromic Enlarged Vestibular Aqueduct.

Otology &amp; neurotology : official publication of the American Otological Society, American Neurotology Society [and] European Academy of Otology and Neurotology
2019

Estimating the concentration of therapeutic range using disease-specific iPS cells: Low-dose rapamycin therapy for Pendred syndrome.

Regenerative therapy
2018

Segmental Maternal UPD of Chromosome 7q in a Patient With Pendred and Silver Russell Syndromes-Like Features.

Frontiers in genetics
2019

Cochlear implantation in a 10-year old boy with Pendred syndrome and extremely enlarged endolymphatic sacs.

Cochlear implants international
2019

Imaging Findings in Syndromes with Temporal Bone Abnormalities.

Neuroimaging clinics of North America
2019

Targeted Next-Generation Sequencing Facilitates Genetic Diagnosis and Provides Novel Pathogenetic Insights into Deafness with Enlarged Vestibular Aqueduct.

The Journal of molecular diagnostics : JMD
2019

CONGENITAL HYPOTHYROIDISM AS A RISK FACTOR FOR CENTRAL HEARING PROCESS DISORDERS.

Revista paulista de pediatria : orgao oficial da Sociedade de Pediatria de Sao Paulo
2018

Homology of pendrin, sodium-iodide symporter and apical iodide transporter.

Frontiers in bioscience (Landmark edition)
2018

Mutation analysis of SLC26A4 (Pendrin) gene in a Brazilian sample of hearing-impaired subjects.

BMC medical genetics
2017

Permanent Childhood Hearing Impairment: Aetiological Evaluation of Infants identified through the Irish Newborn Hearing Screening Programme.

Irish medical journal
2018

Syndromic Hearing Loss: A Brief Review of Common Presentations and Genetics.

Journal of pediatric genetics
2017

[Results of molecular genetic testing in Russian patients with Pendred syndrome and allelic disorders].

Genetika
2018

Hereditary and familial thyroid tumours.

Histopathology
2017

Hearing-impaired young people - a physician's guide .

Clinical medicine (London, England)
2016

Human SLC26A4/Pendrin STAS domain is a nucleotide-binding protein: Refolding and characterization for structural studies.

Biochemistry and biophysics reports
2017

Molecular analysis of human solute carrier SLC26 anion transporter disease-causing mutations using 3-dimensional homology modeling.

Biochimica et biophysica acta. Biomembranes
2017

Enlarged vestibular aqueduct: Audiological and genetical features in children and adolescents.

International journal of pediatric otorhinolaryngology
2017

Genetic Alterations in Pendrin (SLC26A4) Gene in Adult Hypothyroid Patients.

Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme
2017

Endocrine Glands and Hearing: Auditory Manifestations of Various Endocrine and Metabolic Conditions.

Indian journal of endocrinology and metabolism
2017

HASHIMOTO THYROIDITIS AND VESTIBULAR DYSFUNCTION.

Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists
2017

Discovery of (2-aminophenyl)methanol as a new molecular chaperone that rescues the localization of P123S mutant pendrin stably expressed in HEK293 cells.

Bioorganic &amp; medicinal chemistry
2017

Exome sequencing identifies SLC26A4, GJB2, SCARB2 and DUOX2 mutations in 2 siblings with Pendred syndrome in a Malaysian family.

Orphanet journal of rare diseases
2016

[The clinical definition and etiology of Pendred syndrome (a review of the literature and clinical observations)].

Vestnik otorinolaringologii
2016

Diagnosis and Management of Congenital Sensorineural Hearing Loss.

Current treatment options in pediatrics
2017

Cochlear Cell Modeling Using Disease-Specific iPSCs Unveils a Degenerative Phenotype and Suggests Treatments for Congenital Progressive Hearing Loss.

Cell reports
2017

A Novel Mutation in SLC26A4 Causes Nonsyndromic Autosomal Recessive Hearing Impairment.

Otology &amp; neurotology : official publication of the American Otological Society, American Neurotology Society [and] European Academy of Otology and Neurotology
2017

Hearing loss associated with enlarged vestibular aqueduct and zero or one mutant allele of SLC26A4.

The Laryngoscope
2017

Mapping pathogenic mutations suggests an innovative structural model for the pendrin (SLC26A4) transmembrane domain.

Biochimie
2016

Delayed diagnosis of Pendred syndrome.

BMJ case reports
2017

Unresolved questions regarding human hereditary deafness.

Oral diseases
2016

Cochlear implantation in Pendred syndrome and non-syndromic enlarged vestibular aqueduct - clinical challenges, surgical results, and complications.

Acta oto-laryngologica
2016

Further characterisation of the recently described SLC26A4 c.918+2T>C mutation and reporting of a novel variant predicted to be damaging.

Acta otorhinolaryngologica Italica : organo ufficiale della Societa italiana di otorinolaringologia e chirurgia cervico-facciale
2017

A nationwide study on enlargement of the vestibular aqueduct in Japan.

Auris, nasus, larynx
2016

The HSP70 co-chaperone DNAJC14 targets misfolded pendrin for unconventional protein secretion.

Nature communications
2016

Overlapping expression of anion exchangers in the cochlea of a non-human primate suggests functional compensation.

Neuroscience research
2016

Pendred Syndrome in a Newborn with Neck Swelling: A Case Report.

Journal of tropical pediatrics
2016

Mutation screening of the SLC26A4 gene in a cohort of 192 Chinese patients with congenital hypothyroidism.

Archives of endocrinology and metabolism
2016

Targeted Next-Generation Sequencing Analysis of a Pendred Syndrome-Associated Thyroid Carcinoma.

Endocrine pathology
2016

Effect of SLC26 anion transporter disease-causing mutations on the stability of the homologous STAS domain of E. coli DauA (YchM).

The Biochemical journal
2015

Genetics of Hearing Loss: Syndromic.

Otolaryngologic clinics of North America
2016

Correlation of vestibular aqueduct size with air-bone gap in enlarged vestibular aqueduct syndrome.

The Laryngoscope
2016

Patients with Pendred syndrome: is cochlear implantation beneficial?

Clinical otolaryngology : official journal of ENT-UK ; official journal of Netherlands Society for Oto-Rhino-Laryngology &amp; Cervico-Facial Surgery
2015

Pendrin and anoctamin as mediators of apical iodide efflux in thyroid cells.

Current opinion in endocrinology, diabetes, and obesity
2015

[Pendred syndrome and nonsyndromic related deafness: a same entity?].

Bulletin de l'Academie nationale de medecine
Ver todos os 192 no EuropePMC

Associações

Organizações que acompanham esta doença — pra ter apoio e orientação

Ainda não temos associações cadastradas para Síndrome Pendred.

É de uma associação que acompanha esta doença? Fale com a gente →

Comunidades

Grupos ativos de quem convive com esta doença aqui no Raras

Ainda não existe comunidade no Raras para Síndrome Pendred

Pacientes, familiares e cuidadores se organizam em comunidades pra compartilhar experiências, fazer perguntas e se apoiar. Você pode ser o primeiro.

Tire suas dúvidas

Perguntas, dicas e experiências compartilhadas aqui na página

Participe da discussão

Faça login para postar dúvidas, compartilhar experiências e interagir com especialistas.

Fazer login

Doenças relacionadas

Doenças com sintomas parecidos — ajudam quem ainda está buscando diagnóstico

Ordenadas pelo número de sintomas em comum.

Referências e fontes

Bases de dados externas citadas neste artigo

Publicações científicas

Artigos indexados no PubMed ligados a esta doença no grafo RarasNet — título, periódico e PMID direto da fonte, sem intermediação de IA.

  1. Foxi1 regulates multipotent mucociliary progenitors and ionocyte specification through transcriptional and epigenetic mechanisms.
    PLoS biology· 2026· PMID 41490055mais citado
  2. Thyroid and breast carcinomas in a patient with Pendred syndrome: a case report and literature review.
    Frontiers in oncology· 2026· PMID 41695370mais citado
  3. Assessing the Functional Significance of Novel and Rare Variants of the SLC26A4 Gene Found in Patients with Hearing Loss by Minigene Assay.
    International journal of molecular sciences· 2025· PMID 41226768mais citado
  4. Low Efficiency of Homology-Independent Targeted Integration for CRISPR/Cas9 Correction in the Vicinity of the SLC26A4 c.919-2A&gt;G Variant.
    International journal of molecular sciences· 2025· PMID 40507794mais citado
  5. Comparative genomic profiling of SLC26A4-expressing cells in the inner ear and other organs.
    PloS one· 2025· PMID 39932986mais citado
  6. Concomitant Mutations in the Thyroglobulin and SLC26A4 Genes Leading to Fetal Goiter and Congenital Hypothyroidism in a Patient With Pendred Syndrome.
    Case Rep Endocrinol· 2025· PMID 41394090recente
  7. [Congenital hearing loss in children].
    Ugeskr Laeger· 2025· PMID 41126706recente

Bases de dados e fontes oficiais

Identificadores e referências canônicas usadas para montar este verbete.

  1. ORPHA:705(Orphanet)
  2. OMIM OMIM:274600(OMIM)
  3. MONDO:0010134(MONDO)
  4. GARD:4271(GARD (NIH))
  5. Variantes catalogadas(ClinVar)
  6. Busca completa no PubMed(PubMed)
  7. Q1707822(Wikidata)

Dados compilados pelo RarasNet a partir de fontes abertas (Orphanet, OMIM, MONDO, PubMed/EuropePMC, ClinicalTrials.gov, DATASUS, PCDT/MS). Este conteúdo é informativo e não substitui avaliação médica.

Conteúdo mantido por Agente Raras · Médicos e pesquisadores podem colaborar

Síndrome Pendred
Compêndio · Raras BR

Síndrome Pendred

ORPHA:705 · MONDO:0010134
Prevalência
1-9 / 100 000
Herança
Autosomal recessive
CID-10
E07.1 · Bócio disormonogênico
CID-11
Início
Infancy, Neonatal
Prevalência
7.0 (Europe)
MedGen
UMLS
C0271829
EuropePMC
Wikidata
Papers 10a
DiscussaoAtiva

Nenhuma novidade ainda. O agente esta monitorando.

0membros
0novidades